Hochschulschrift
Charakterisierung von Osteoprotegerin (OPG) und receptor activator of NF-κB-ligand [NF-kappa-B-ligand] (RANKL) in der Schilddrüse
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Deutsch
- Notes
-
Marburg, Univ., Diss., 2005
- Keyword
-
Schilddrüse ; Basedow-Krankheit ; Autoaggressionskrankheit
Endokrinologie
- Creator
-
Kluger, Sibylle
- URN
-
urn:nbn:de:hebis:04-z2005-07084
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:26 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Object type
- Hochschulschrift
Associated
- Kluger, Sibylle
Other Objects (12)
Serum proinflammatory cytokines, receptor activator of nuclear factor kappa-Β ligand (RANKL), osteoprotegerin (OPG) and RANKL/OPG ratio in mild and severe COVID-19
Regulation von Osteoprotegerin (OPG) und receptor activator of nuclear factor-κB [factor-kappa-B] ligand (RANKL) in humanen Schilddrüsenkarzinomzellen
Cucumber seed polypeptides regulate RANKL-induced osteoclastogenesis through OPG/RANKL/RANK and NF-κB
LMS-based continuous pediatric reference values for soluble receptor activator of nuclear factor kappa B ligand (sRANKL) and osteoprotegerin (OPG) in the HARP cohort
Osteoprotegerin and RANKL-RANK-OPG-TRAIL signalling axis in heart failure and other cardiovascular diseases
![Regulated gene over-expression of receptor activator of NF-κB [NF-kappa-B] ligand (RANKL) in a porcine animal model](/assets/placeholder/searchResultMediaNoDigitisedMedia.png)
Regulated gene over-expression of receptor activator of NF-κB [NF-kappa-B] ligand (RANKL) in a porcine animal model
Auswirkung von Bisphosphonaten auf die Expression von Osteoprotegerin (OPG) und Receptor activator of nuclear factor kappa-B ligand (RANKL) in Osteoblastenkulturen aus Unterkiefer und Becken : eine Pilotstudie am Hausschwein
Regulated gene over-expression of Receptor Activator of NF-kappaB Ligand (RANKL) in a porcine animal model
Die Rolle von Receptor Activator of NF-kB (RANK) und Receptor Activator of NF-kB Ligand (RANKL) beim humanen Pankreaskarzinom in vitro
Osteoprotegerin (OPG) as a biomarker for diabetic cardiovascular complications
RANK/RANKL/OPG system in the intervertebral disc
Selective inhibition of receptor activator of NF-κB ligand (RANKL) in hematopoietic cells improves outcome after experimental myocardial infarction
Serum proinflammatory cytokines, receptor activator of nuclear factor kappa-Β ligand (RANKL), osteoprotegerin (OPG) and RANKL/OPG ratio in mild and severe COVID-19
Regulation von Osteoprotegerin (OPG) und receptor activator of nuclear factor-κB [factor-kappa-B] ligand (RANKL) in humanen Schilddrüsenkarzinomzellen
Cucumber seed polypeptides regulate RANKL-induced osteoclastogenesis through OPG/RANKL/RANK and NF-κB
LMS-based continuous pediatric reference values for soluble receptor activator of nuclear factor kappa B ligand (sRANKL) and osteoprotegerin (OPG) in the HARP cohort
Osteoprotegerin and RANKL-RANK-OPG-TRAIL signalling axis in heart failure and other cardiovascular diseases
Regulated gene over-expression of receptor activator of NF-κB [NF-kappa-B] ligand (RANKL) in a porcine animal model
Auswirkung von Bisphosphonaten auf die Expression von Osteoprotegerin (OPG) und Receptor activator of nuclear factor kappa-B ligand (RANKL) in Osteoblastenkulturen aus Unterkiefer und Becken : eine Pilotstudie am Hausschwein
Regulated gene over-expression of Receptor Activator of NF-kappaB Ligand (RANKL) in a porcine animal model
Die Rolle von Receptor Activator of NF-kB (RANK) und Receptor Activator of NF-kB Ligand (RANKL) beim humanen Pankreaskarzinom in vitro
Osteoprotegerin (OPG) as a biomarker for diabetic cardiovascular complications
RANK/RANKL/OPG system in the intervertebral disc
Selective inhibition of receptor activator of NF-κB ligand (RANKL) in hematopoietic cells improves outcome after experimental myocardial infarction
Serum proinflammatory cytokines, receptor activator of nuclear factor kappa-Β ligand (RANKL), osteoprotegerin (OPG) and RANKL/OPG ratio in mild and severe COVID-19
Regulation von Osteoprotegerin (OPG) und receptor activator of nuclear factor-κB [factor-kappa-B] ligand (RANKL) in humanen Schilddrüsenkarzinomzellen
Cucumber seed polypeptides regulate RANKL-induced osteoclastogenesis through OPG/RANKL/RANK and NF-κB
LMS-based continuous pediatric reference values for soluble receptor activator of nuclear factor kappa B ligand (sRANKL) and osteoprotegerin (OPG) in the HARP cohort
Osteoprotegerin and RANKL-RANK-OPG-TRAIL signalling axis in heart failure and other cardiovascular diseases
Regulated gene over-expression of receptor activator of NF-κB [NF-kappa-B] ligand (RANKL) in a porcine animal model
Auswirkung von Bisphosphonaten auf die Expression von Osteoprotegerin (OPG) und Receptor activator of nuclear factor kappa-B ligand (RANKL) in Osteoblastenkulturen aus Unterkiefer und Becken : eine Pilotstudie am Hausschwein
Regulated gene over-expression of Receptor Activator of NF-kappaB Ligand (RANKL) in a porcine animal model
Die Rolle von Receptor Activator of NF-kB (RANK) und Receptor Activator of NF-kB Ligand (RANKL) beim humanen Pankreaskarzinom in vitro
Osteoprotegerin (OPG) as a biomarker for diabetic cardiovascular complications
RANK/RANKL/OPG system in the intervertebral disc